Kenya has become the first messenger RNA (mRNA) hub in Africa after agreeing to host biotechnology company Moderna.
Moderna Monday announced that, with the help of the United States government, it will invest $500 million which is expected to cater for the production of about 500 million vaccine doses for the African continent.
